Applied Therapeutics, Inc. Operating Lease, Liability, Current
Applied Therapeutics, Inc. had Operating Lease, Liability, Current of $467.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2025-11-13
- 2025-09-30: Operating Lease, Liability, Current $467.00K.
- 2025-06-30: Operating Lease, Liability, Current $447.00K.
- 2025-03-31: Operating Lease, Liability, Current $426.00K.
- 2024-12-31: Operating Lease, Liability, Current $406.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2025-09-30 | $467.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $447.00K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $426.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $406.00K 10-Q · filed 2025-11-13 |
| 2024-09-30 | $264.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $185.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $308.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $429.00K 10-K · filed 2025-04-15 |
| 2023-09-30 | $491.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $486.00K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $483.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $477.00K 10-K · filed 2024-03-06 |
| 2022-09-30 | $470.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $462.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $453.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $442.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $436.00K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $426.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $415.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $406.00K 10-K · filed 2022-03-10 |
| 2020-09-30 | $380.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $372.00K 10-Q · filed 2020-08-11 |
| 2020-03-31 | $364.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $356.00K 10-K · filed 2021-03-18 |